| |
| |
|
| Insider
Information: |
Rocklage Scott M |
| Relationship: |
10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
30,383,740 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$149,931,884 |
|
|
| Total
Shares |
30,383,740 |
|
|
| Total
Value |
$149,931,884 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relypsa Inc |
RLYP |
Director, 10% Owner |
|
0 |
2013-11-20 |
62,316 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
Director, 10% Owner |
|
0 |
2015-02-04 |
2,549,211 |
Premium* |
|
|
Vive Medical Inc |
VIVE |
10% Owner |
2015-05-14 |
0 |
2015-05-14 |
288,447 |
Premium* |
|
|
Pulmatrix Inc |
PULM |
Director |
2015-06-15 |
0 |
2015-06-16 |
168,873 |
Premium* |
|
|
Audentes Therapeutics, Inc. |
BOLD |
former 10% owner |
2017-04-24 |
0 |
2017-04-24 |
2,500,113 |
Premium* |
|
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2017-11-21 |
0 |
2017-11-21 |
130,135 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Former 10% holder |
|
0 |
2020-10-05 |
2,037,654 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
10% Owner |
2020-11-11 |
0 |
2020-11-11 |
384,496 |
Premium* |
|
|
Rallybio Corp |
RLYB |
10% Owner |
2021-08-02 |
0 |
2023-03-07 |
3,630,724 |
Premium* |
|
|
Pear Therapeutics, Inc |
PEAR |
10% Owner |
|
0 |
2021-12-03 |
18,631,771 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2023-03-07 |
4 |
S |
$8.20 |
$820,000 |
I/I |
(100,000) |
2,378,969 |
0 |
- |
|
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2022-06-03 |
4 |
S |
$12.50 |
$1,875,000 |
I/I |
(150,000) |
2,478,969 |
0 |
- |
|
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2022-05-23 |
4 |
S |
$13.00 |
$1,300,000 |
I/I |
(100,000) |
2,578,640 |
0 |
- |
|
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2022-02-08 |
4 |
S |
$13.05 |
$2,740,500 |
I/I |
(210,000) |
2,645,087 |
0 |
- |
|
| PEAR |
Pear Therapeutics, Inc |
10% Owner |
– – • |
2021-12-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
18,631,771 |
|
% |
|
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2021-08-02 |
4 |
B |
$13.00 |
$7,999,992 |
I/I |
615,384 |
1,406,098 |
1.5 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
Former 10% holder |
– – • |
2020-11-11 |
4 |
S |
$13.66 |
$10,928,000 |
I/I |
(800,000) |
384,496 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Former 10% holder |
– – – |
2020-10-05 |
4 |
S |
$25.30 |
$4,427,500 |
I/I |
(175,000) |
138,497 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • • |
2020-06-16 |
4 |
S |
$33.30 |
$4,001,461 |
I/I |
(120,164) |
75,965 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • • |
2020-06-11 |
4 |
S |
$28.75 |
$7,044,412 |
I/I |
(245,000) |
80,772 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2020-05-19 |
4 |
S |
$35.15 |
$8,963,250 |
I/I |
(255,000) |
90,572 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
|
• • – |
2019-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,506,650 |
100,772 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
|
– • – |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,670 |
|
- |
|
| SCPH |
Scpharmaceuticals Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
B |
$14.00 |
$9,166,668 |
I/I |
654,762 |
130,135 |
1.5 |
- |
|
| SCPH |
Scpharmaceuticals Inc. |
10% Owner |
– – • |
2017-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,598,675 |
103,945 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
former 10% owner |
– – – |
2017-04-24 |
4 |
B |
$14.50 |
$2,499,989 |
I/I |
172,413 |
2,500,113 |
0.01 |
- |
|
| PULM |
Pulmatrix Inc |
Director |
– • – |
2015-06-16 |
4 |
B |
$6.88 |
$266,784 |
I/I |
38,805 |
168,873 |
2.1 |
- |
|
| PULM |
Pulmatrix Inc |
Director |
– • – |
2015-06-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,322,222 |
164,058 |
0 |
- |
|
| VIVE |
Vive Medical Inc |
10% Owner |
• • • |
2015-05-14 |
4 |
B |
$0.37 |
$250,000 |
I/I |
675,675 |
288,447 |
1.5 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • • |
2015-02-04 |
4 |
B |
$5.00 |
$2,000,000 |
I/I |
400,000 |
2,549,211 |
2.25 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • • |
2014-07-15 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,214,910 |
|
- |
|
| RLYP |
Relypsa Inc |
Director |
– • • |
2013-11-20 |
4 |
B |
$11.00 |
$103,004 |
I/I |
9,364 |
62,316 |
2.25 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • • |
2013-11-20 |
4 |
D |
$11.00 |
$2,431 |
I/I |
(221) |
52,952 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • • |
2013-11-20 |
4 |
OE |
$0.17 |
$2,384 |
I/I |
14,024 |
52,994 |
0 |
- |
|
| RLYP |
Relypsa Inc |
Director |
– • • |
2013-11-20 |
4 |
A |
$0.00 |
$0 |
I/I |
7,340 |
39,149 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
